Please use this identifier to cite or link to this item: https://doi.org/10.1097/01.coc.0000046592.90778.FC
DC FieldValue
dc.titleAdjuvant High-Dose Rate Brachytherapy after Chemoradiation for Treatment of Early T-Stage Nasopharyngeal Carcinoma
dc.contributor.authorLu, J.J.
dc.contributor.authorShakespeare, T.
dc.contributor.authorBack, M.
dc.contributor.authorMukherjee, R.
dc.contributor.authorWynne, C.J.
dc.contributor.authorGoh, B.C.
dc.contributor.authorTan, K.S.L.
dc.contributor.authorTiong, C.E.
dc.date.accessioned2012-04-02T07:54:14Z
dc.date.available2012-04-02T07:54:14Z
dc.date.issued2004
dc.identifier.citationLu, J.J., Shakespeare, T., Back, M., Mukherjee, R., Wynne, C.J., Goh, B.C., Tan, K.S.L., Tiong, C.E. (2004). Adjuvant High-Dose Rate Brachytherapy after Chemoradiation for Treatment of Early T-Stage Nasopharyngeal Carcinoma. American Journal of Clinical Oncology: Cancer Clinical Trials 27 (2) : 132-135. ScholarBank@NUS Repository. https://doi.org/10.1097/01.coc.0000046592.90778.FC
dc.identifier.issn02773732
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/32230
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1097/01.coc.0000046592.90778.FC
dc.sourceScopus
dc.subjectBrachytherapy
dc.subjectChemoradiation
dc.subjectHigh-dose rate
dc.subjectNasopharyngeal carcinoma
dc.typeArticle
dc.contributor.departmentPHARMACOLOGY
dc.contributor.departmentOTOLARYNGOLOGY
dc.description.doi10.1097/01.coc.0000046592.90778.FC
dc.description.sourcetitleAmerican Journal of Clinical Oncology: Cancer Clinical Trials
dc.description.volume27
dc.description.issue2
dc.description.page132-135
dc.description.codenAJCOD
dc.identifier.isiut000220711100006
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

2
checked on Aug 15, 2019

WEB OF SCIENCETM
Citations

2
checked on Aug 15, 2019

Page view(s)

151
checked on Aug 19, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.